Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.
Test scores for children with NAS, on average, were sharply lower than those of both groups of children.
Patients reported significant cognitive difficulties from pre-chemotherapy to post-chemotherapy and from pre-chemotherapy to 6-month follow-up.
Patients with dysglycemia have more brain infarcts and white matter hyperintensities and a lower total white matter volume.
Those with previous cognitive impairment saw a more pronounced improvement.
The effect of antihypertensive drugs and stains on cognition is uncertain.
In patients with suspected coronary heart disease, mild cognitive impairment was common.
Studying cognition deficits during the clinical high risk period allows researchers to look at changes in the near psychotic state before chronicity and long-term medication use obscure the core deficits.
There were significantly lower levels of anxiety/depression and fatigue noted in the intervention group.
Patients with these EEG characteristics may benefit from early screening and intervention.
Future studies should explore ways to increase ongoing exercise adherence among participants
Ghrelin was a significant predictor for executive function impairment in patients with T2DM.
Aerobic exercise benefits cognition, but not after high levels of prenatal mercury exposure.
In subjects with a low risk of preclinical Alzheimer's disease indexed by the absence of MTA, findings were confirmed.
There has been a lack of research on the association between anxiety and dementia.
Dementia risk was elevated in those who had higher scores on cognitive tests at baseline.
Results indicate that patients with AUD show significant impairments in social problem resolution task.
The authors recommend a nurse-led initiative to help patients discuss what they experienced.
The authors acknowledged that the study was limited and plan to follow the group through 4 years of treatment.
Intracranial disease control at 3 months was better with combination therapy; however it did not appear to impact overall survival.
The researchers found evidence of several psychoactive drugs, which may contribute to delirium.
Higher LDL-C variability was associated with lower cognitive test scores, including immediate and delayed recall.
No effect seen at 6 or 10+ years after menopause onset.
Impairments in memory after cancer treatment might be more emotional, the researchers suggest.
This is the first study to examine the role of CSF biomarkers in the diagnosis of patients with cognitive symptoms and psychiatric disorders in routine daily clinical practice.
There have been no studies to investigate the utility of MRI biomarkers to estimate small vessel disease in patients with CAA.
Placebo effect needs to be accounted for before reporting results.
For the most part, symptoms tend to subside after treatment initiation.
More research needs to be performed in girls.
Surprisingly, the researchers found that snoring alone has an impact on cognitive function.
Neurology Advisor Articles
- No Difference in Neurodevelopment in Children Conceived by Assisted Reproduction
- Case Report: Treatment With Alemtuzumab May Prompt Severe CNS Disease
- Treating Pain in Depression May Help Improve Cognition
- The Handoff: Your Week in Neurology News - 1/19/17
- FDA Warns of Implantable Infusion Pumps in MRI